Sunday, November 3, 2024
HomeTagsMichael S. Weiss

Michael S. Weiss

TG Therapeutics Announces FDA Approval of BRIUMVI

TG Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has approved BRIUMVI, for the treatment of relapsing forms of multiple sclerosis (RMS),...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics